MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 592840 | Name: Amopyroquine

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Amopyroquine has anticholinesterase activity.

Chemical Structure

Amopyroquine
Amopyroquine
CAS#550-81-2 (free base)

Theoretical Analysis

MedKoo Cat#: 592840

Name: Amopyroquine

CAS#: 550-81-2 (free base)

Chemical Formula: C20H20ClN3O

Exact Mass: 353.1295

Molecular Weight: 353.85

Elemental Analysis: C, 67.89; H, 5.70; Cl, 10.02; N, 11.88; O, 4.52

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
10350-81-9 (HCl) 550-81-2 (free base)
Synonym
Amopyroquine
IUPAC/Chemical Name
4-((7-Chloro-4-quinolyl)amino)-alpha-1-pyrrolidinyl-o-cresol
InChi Key
YNWCUCSDUMVJKR-UHFFFAOYSA-N
InChi Code
InChI=1S/C20H20ClN3O/c21-15-3-5-17-18(7-8-22-19(17)12-15)23-16-4-6-20(25)14(11-16)13-24-9-1-2-10-24/h3-8,11-12,25H,1-2,9-10,13H2,(H,22,23)
SMILES Code
ClC1=CC=C2C(NC3=CC=C(O)C(CN4CCCC4)=C3)=CC=NC2=C1
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 353.85 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Le Fur N, Hochart G, Larchanché PE, Melnyk P. Buchwald reaction as the key step for the synthesis of metabolically more stable analogs of amodiaquine. Eur J Med Chem. 2011 Jul;46(7):3052-7. doi: 10.1016/j.ejmech.2011.04.047. Epub 2011 Apr 21. PubMed PMID: 21565435. 2: Păunescu E, Susplugas S, Boll E, Varga R, Mouray E, Grosu I, Grellier P, Melnyk P. Replacement of the 4'-hydroxy group of amodiaquine and amopyroquine by aromatic and aliphatic substituents: synthesis and antimalarial activity. ChemMedChem. 2009 Apr;4(4):549-61. doi: 10.1002/cmdc.200800318. PubMed PMID: 19212949. 3: Paunescu E, Susplugas S, Boll E, Varga RA, Mouray E, Grellier P, Melnyk P. Synthesis and antimalarial activity of new amino analogues of amodiaquine. Med Chem. 2008 Sep;4(5):407-25. PubMed PMID: 18782038. 4: Naisbitt DJ, Ruscoe JE, Williams D, O'Neill PM, Pirmohamed M, Park BK. Disposition of amodiaquine and related antimalarial agents in human neutrophils: implications for drug design. J Pharmacol Exp Ther. 1997 Feb;280(2):884-93. PubMed PMID: 9023303. 5: Hawley SR, Bray PG, O'Neill PM, Naisbitt DJ, Park BK, Ward SA. Manipulation of the N-alkyl substituent in amodiaquine to overcome the verapamil-sensitive chloroquine resistance component. Antimicrob Agents Chemother. 1996 Oct;40(10):2345-9. PubMed PMID: 8891142; PubMed Central PMCID: PMC163532. 6: Trouiller P. [Research and pharmaceutical development on the subject of communicable diseases in the intertropical region]. Sante. 1996 Sep-Oct;6(5):299-307. French. PubMed PMID: 8998593. 7: Pussard E, Chassard D, Clavier F, Bry P, Verdier F. Pharmacokinetics and metabolism of amopyroquin after administration of two doses of 6 mg/kg im 24 h apart to healthy volunteers. J Antimicrob Chemother. 1994 Nov;34(5):803-8. PubMed PMID: 7706177. 8: Pussard E, Verdier F. Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics. Fundam Clin Pharmacol. 1994;8(1):1-17. Review. PubMed PMID: 8181791. 9: Gaudebout C, Pussard E, Clavier F, Gueret D, Le Bras J, Brandicourt O, Verdier F. Efficacy of intramuscular amopyroquin for treatment of Plasmodium falciparum malaria in the Gabon Republic. Antimicrob Agents Chemother. 1993 May;37(5):970-4. PubMed PMID: 8517723; PubMed Central PMCID: PMC187865. 10: Basco LK, Le Bras J. In vitro activity of monodesethylamodiaquine and amopyroquine against African isolates and clones of Plasmodium falciparum. Am J Trop Med Hyg. 1993 Jan;48(1):120-5. PubMed PMID: 8427380. 11: Basco LK, Le Bras J. In vitro activity of pyronaridine against African strains of Plasmodium falciparum. Ann Trop Med Parasitol. 1992 Oct;86(5):447-54. PubMed PMID: 1288425. 12: Basco LK, Le Bras J. Potentiation of monodesethylamodiaquine and amopyroquine with desipramine against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg. 1991 Jul-Aug;85(4):447-8. PubMed PMID: 1755046. 13: Verdier F, Pussard E, Clavier F, Le Bras J, Gaudebout C. Pharmacokinetics of intramuscular amopyroquin in healthy subjects and determination of a therapeutic regimen for Plasmodium falciparum malaria. Antimicrob Agents Chemother. 1989 Mar;33(3):316-21. PubMed PMID: 2658783; PubMed Central PMCID: PMC171485. 14: Pussard E, Verdier F, Faurisson F, Clavier F, Simon F, Gaudebout C. Disposition of amopyroquin in rats and rabbits and in vitro activity against Plasmodium falciparum. Antimicrob Agents Chemother. 1988 Apr;32(4):568-72. PubMed PMID: 3288115; PubMed Central PMCID: PMC172222. 15: Pussard E, Clavier F, Verdier F. Liquid chromatographic determination of amopyroquine in rabbit plasma and red blood cells. J Chromatogr. 1987 Oct 9;421(1):192-7. PubMed PMID: 3429566. 16: Coleman MD, Edwards G, Braithwaite IM, Breckenridge AM. High-performance liquid chromatographic method for the determination of amopyroquine in biological fluids. J Chromatogr. 1987 Feb 20;414(1):242-7. PubMed PMID: 3571390. 17: Lim LY, Go ML. The anticholinesterase activity of mefloquine. Clin Exp Pharmacol Physiol. 1985 Sep-Oct;12(5):527-31. Erratum in: Clin Exp Pharmacol Physiol 1986 Jun;13(6):511. PubMed PMID: 3878759. 18: Fink E. Assessment of causal prophylactic activity in Plasmodium berghei yoelii and its value for the development of new antimalarial drugs. Bull World Health Organ. 1974;50(3-4):213-22. PubMed PMID: 4155355; PubMed Central PMCID: PMC2481207. 19: MAGUIRE A. A TRIAL OF AMOPYROQUIN IN THE TREATMENT OF CHRONIC DISCOID LUPUS ERYTHEMATOSUS. Br J Dermatol. 1964 Apr;76:191-5. PubMed PMID: 14140744. 20: BARTHOLOMEW LE, DUFF IF. AMOPYROQUIN (PROPOQUIN) IN RHEUMATOID ARTHRITIS. Arthritis Rheum. 1963 Aug;6:356-63. PubMed PMID: 14052856.